Clinical trial
A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of…
NCT00495144 · Threshold Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00495144 |
|---|---|
| Title | A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors |
| Official title | A Phase I, Multi-Center, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors |
| Lead sponsor | Threshold Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors, Hypoxia |
| Intervention type | Drug |
| Interventions | TH-302 |
| Enrollment | 129 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Jun 1, 2012 |
| First posted | Jul 2, 2007 |
| Last update posted | Jul 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: